论文部分内容阅读
目的 分析总结传染性非典型肺炎 (SARS)腹泻的临床表现及药物治疗。方法 对 2 2 9例SARS患者的临床资料进行回顾性分析。分为三组 :A组为发病 2周内发生腹泻者 ,B组为发病 2周后发生腹泻者 ,C组为无腹泻发生。结果 A组腹泻时CD4降低比例 (72 .73% )高于B组 (2 3.0 8% ) ,P <0 .0 5。B组 (6 5 .2 2 % )头孢菌素使用比例高于A组 (17.6 5 % )、C组 (4 0 .2 2 % ) ,P <0 .0 5。C组抗病毒药使用比例 (75 .5 4 % )高于B组 (5 2 .17% ) ,P<0 .0 5。结论 SARS患者在发病 2周内腹泻与用药无关。发病 2周后腹泻与使用头孢菌素有关。在SARS的后期 ,抗病毒药物能够抑制SARS病毒的复制 ,对防治腹泻有帮助。
Objective To analyze and summarize the clinical manifestation and drug treatment of SARS diarrhea. Methods The clinical data of 2 29 SARS patients were retrospectively analyzed. Divided into three groups: A group of patients with diarrhea within 2 weeks of onset, B group of patients with diarrhea after 2 weeks of onset, C group without diarrhea. Results The proportion of CD4 in group A was higher than that in group B (2.30% vs 72.0%, P <0.05). The use of cephalosporins in group B (65.22%) was higher than that in group A (17.65%) and group C (402.2%), P <0.05. The use of antivirals in group C (75.54%) was higher than that in group B (52.17%), P <0.05. Conclusion SARS patients have no relationship with medication within 2 weeks after onset. Two weeks after the onset of diarrhea and the use of cephalosporins. In the latter part of SARS, antiviral drugs can inhibit the replication of the SARS virus and help prevent and cure diarrhea.